Feb.24 -- Johnson & Johnson’s Covid-19 vaccine is safe and 72% effective in a U.S. clinical trial, Food and Drug Administration staff said. Bloomberg Intelligence's Sam Fazeli has more on "Bloomberg Surveillance."